AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $214,000 | -20.1% | 18,162 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $268,000 | -80.9% | 18,162 | -82.5% | 0.00% | -85.0% |
| Q1 2020 | $1,401,000 | -31.3% | 103,776 | +23.1% | 0.02% | -13.0% |
| Q4 2019 | $2,038,000 | +25.8% | 84,317 | 0.0% | 0.02% | +21.1% |
| Q3 2019 | $1,620,000 | -33.8% | 84,317 | +1.9% | 0.02% | -36.7% |
| Q2 2019 | $2,446,000 | -37.4% | 82,774 | +0.7% | 0.03% | -37.5% |
| Q1 2019 | $3,905,000 | +37.8% | 82,196 | +4.8% | 0.05% | +23.1% |
| Q4 2018 | $2,833,000 | -34.7% | 78,460 | +11.3% | 0.04% | -25.0% |
| Q3 2018 | $4,338,000 | -2.0% | 70,477 | +7.5% | 0.05% | 0.0% |
| Q2 2018 | $4,428,000 | +29.1% | 65,548 | +3.7% | 0.05% | +26.8% |
| Q1 2018 | $3,429,000 | -8.5% | 63,220 | +0.8% | 0.04% | -6.8% |
| Q4 2017 | $3,748,000 | +25.5% | 62,720 | +2.1% | 0.04% | +22.2% |
| Q3 2017 | $2,986,000 | +100.8% | 61,447 | +117.2% | 0.04% | +89.5% |
| Q2 2017 | $1,487,000 | +48.1% | 28,294 | +27.7% | 0.02% | +46.2% |
| Q1 2017 | $1,004,000 | +19.8% | 22,149 | 0.0% | 0.01% | +18.2% |
| Q4 2016 | $838,000 | +0.2% | 22,149 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $836,000 | +42.2% | 22,149 | -33.7% | 0.01% | +37.5% |
| Q2 2016 | $588,000 | +44.8% | 33,410 | 0.0% | 0.01% | +60.0% |
| Q1 2016 | $406,000 | -50.1% | 33,410 | 0.0% | 0.01% | -50.0% |
| Q4 2015 | $814,000 | +37.3% | 33,410 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $593,000 | +0.5% | 33,410 | 0.0% | 0.01% | +14.3% |
| Q2 2015 | $590,000 | -43.6% | 33,410 | 0.0% | 0.01% | -41.7% |
| Q1 2015 | $1,047,000 | +7.4% | 33,410 | 0.0% | 0.01% | +9.1% |
| Q4 2014 | $975,000 | +41.1% | 33,410 | 0.0% | 0.01% | +37.5% |
| Q3 2014 | $691,000 | – | 33,410 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |